⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INCY News
Incyte Genomics Inc
Resumen: Incyte presenta nuevos resultados del estudio clínico en fase 3 de tafasitamab en el Congreso Anual 2026 de la American Society of Clinical Oncology (ASCO)
businesswire.com
INCY
Samenvatting: Incyte licht nieuwe gegevens van tafasitamab Fase 3 toe tijdens de 2026 ASCO (American Society of Clinical Oncology) Annual Meeting
businesswire.com
INCY
Riassunto: Incyte evidenzia i nuovi dati su tafasitamab forniti dallo studio di fase 3 al Meeting annuale 2026 della American Society of Clinical Oncology (ASCO)
businesswire.com
INCY
インサイト、2026年米国臨床腫瘍学会（ASCO）年次総会でタファシタマブの第3相臨床試験の最新データを発表
businesswire.com
INCY
Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight
globenewswire.com
AZN
CRSP
NKTR
INCY
IPHA
ABBV
BIIB
ALKS
IMVT
CLRB
IMPP
REGN
THO
AUTL
KYMR
CBIO
GILD
THE SKIN OF COLOR SOCIETY (SOCS) SUCCESSFULLY PRESENTS LANDMARK SYMPOSIUM CHAMPIONING EVIDENCE-BASED DERMATOLOGY AND COLLABORATION
prnewswire.com
ABBV
JNJ
ARQT
BMY
LLY
INCY
SNY
REGN
PFE
UCB
BIIB
ORGN
TAK
ELMD
Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
businesswire.com
INCY
Immune Checkpoint Inhibitors Market Report 2026-2030 with Detailed Company Profiles, Grant Analyses, Partnership Evaluations and More
globenewswire.com
BMY
GSK
INCY
NVS
The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight
globenewswire.com
JNJ
PFE
ABBV
LLY
AMGN
INCY
GILD
BHC
AZN
SUN
Zynyz (Incyte: retifanlimab-dlwr) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
INCY